Login
Super Investors SmallCap Growth Fund I

SmallCap Growth Fund I

Principal Funds, Inc · net assets $2.48B · 1220 holdings as of July 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 96.5% · STIV: 3.5% · DE: 0.0%

Financial position

Total assets
$2.52B
Total liabilities
$32.7M
Net assets
$2.48B
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$497K

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $40.9M $43.6M $47.3M
Reinvestment $0 $0 $0
Redemptions $28M $42.5M $29.9M
Net realized gain (non-derivative) $50.7M $181M $38.4M
Net unrealized appreciation (non-derivative) $84M $8.4M $-255M

The three months of the reporting period, as filed; month 3 ends July 31, 2026.

Filing details

Registrant
Principal Funds, Inc
Registrant CIK
898745
Registrant LEI
549300HZGBXSW6DSXF23
Series
SmallCap Growth Fund I
Series ID
S000007175
Series LEI
5493004U8OWJ0X12E116
SEC file number
811-07572
Address
711 High St, Des Moines, US-IA, 50392, US
Phone
515-235-1719
Form
NPORT-P
Filed
September 25, 2026
Report period ends
October 31, 2026
Report month ends
July 31, 2026
Accession number
000089874526001033
Holding Value % of net assets
Principal Funds, Inc - Government Money Market Fund - Class R-6 STIV $85.1M 3.43%
Guardant Health Inc EC $33.4M 1.35%
Esco Technologies Inc EC $28.4M 1.14%
Oceaneering International Inc EC $26.7M 1.07%
Brightspring Health Services Inc EC $24.9M 1.00%
Plexus Corp EC $24M 0.97%
Cogent Biosciences Inc EC $23.8M 0.96%
Enpro Inc EC $23.2M 0.93%
Travere Therapeutics Inc EC $22.6M 0.91%
Rush Street Interactive Inc EC $22.6M 0.91%
Argan Inc EC $22.5M 0.91%
Healthequity Inc EC $21M 0.85%
Nlight Inc EC $20.8M 0.84%
Semtech Corp EC $20.6M 0.83%
Corcept Therapeutics Inc EC $20.4M 0.82%
Legence Corp EC $20.2M 0.81%
Establishment Labs Holdings Inc EC $20.1M 0.81%
Freshpet Inc EC $19.6M 0.79%
Aar Corp EC $18.9M 0.76%
Prosperity Bancshares Inc EC $18.7M 0.75%
Billiontoone Inc EC $18.1M 0.73%
Interdigital Inc EC $18M 0.72%
Zurn Elkay Water Solutions Corp EC $16.9M 0.68%
Fti Consulting Inc EC $16.9M 0.68%
Ccc Intelligent Solutions Holdings Inc EC $16.8M 0.68%
Sitime Corp EC $16.8M 0.68%
Piper Sandler Cos EC $16.8M 0.68%
Chefs' Warehouse Inc/the EC $16.6M 0.67%
Andersen Group Inc EC $16.2M 0.65%
Moog Inc EC $16M 0.64%
Livanova PLC EC $15.9M 0.64%
Spyre Therapeutics Inc EC $15.9M 0.64%
Vse Corp EC $15.9M 0.64%
Mercury Systems Inc EC $15.8M 0.64%
Bio-techne Corp EC $15.7M 0.63%
Cytokinetics Inc EC $15.5M 0.62%
Kratos Defense & Security Solutions Inc EC $15.4M 0.62%
Waste Connections Inc EC $15.2M 0.61%
Spx Technologies Inc EC $14.8M 0.60%
Glaukos Corp EC $14.6M 0.59%
Servicetitan Inc EC $14.5M 0.58%
Sensient Technologies Corp EC $14.4M 0.58%
Trevi Therapeutics Inc EC $14.2M 0.57%
Dianthus Therapeutics Inc EC $14M 0.56%
Axos Financial Inc EC $13.7M 0.55%
Q2 Holdings Inc EC $13.7M 0.55%
Firstcash Holdings Inc EC $13.5M 0.54%
Umb Financial Corp EC $13.2M 0.53%
Jfrog Ltd EC $13.1M 0.53%
Mirum Pharmaceuticals Inc EC $13M 0.53%
Maxlinear Inc EC $13M 0.52%
Palvella Therapeutics Inc EC $12.9M 0.52%
Cardinal Infrastructure Group Inc EC $12.9M 0.52%
Hut 8 Corp EC $12.7M 0.51%
Kulicke & Soffa Industries Inc EC $12.7M 0.51%
Dave Inc EC $12.5M 0.50%
Ceco Environmental Corp EC $12.5M 0.50%
Sharkninja Inc EC $12.3M 0.50%
Encompass Health Corp EC $12.3M 0.50%
Allegiant Travel Co EC $12M 0.48%

Showing top 60 of 1220 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support